Mariner, LLC Precigen, Inc. Transaction History

Mariner, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.08 - $1.85 $165,878 - $284,143	153,591 Added 1049.62%	168,224 $238,000
Q2 2023 Aug 11, 2023	BUY	$0.96 - $1.4 $14,047 - $20,486	14,633 New	14,633 $16,000
Q4 2022 Feb 14, 2023	SELL	$1.27 - $2.26 $9,251 - $16,464	-7,285 Reduced 28.19%	18,556 $28,000
Q3 2022 Nov 10, 2022	BUY	$1.41 - $2.79 $36,435 - $72,096	25,841 New	25,841 $55,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $179M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.